Skip to main content
Fig. 2 | Arthritis Research & Therapy

Fig. 2

From: Impact of disease activity and treatment of comorbidities on the risk of myocardial infarction in rheumatoid arthritis

Fig. 2

Development of mean C-reactive protein (CRP, mg/L), mean erythrocyte sedimentation rate (ESR, mm/h) and mean disease activity score based on 28 joints (DAS28) (all presented with error bars) at baseline, month 3 and month 6 in cases, matched controls and the remainder of the RABBIT cohort (left) and 18 months prior to the myocardial infarction (MI)/index date in cases and matched controls (right)

Back to article page